Compare GLBE & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLBE | NOVT |
|---|---|---|
| Founded | 2013 | 1968 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.0B |
| IPO Year | 2020 | 1999 |
| Metric | GLBE | NOVT |
|---|---|---|
| Price | $40.66 | $146.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | $47.08 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 1.4M | 404.3K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $31.78 | $8.61 |
| Revenue Next Year | $24.45 | $6.57 |
| P/E Ratio | ★ $89.26 | $177.46 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $26.85 | $98.27 |
| 52 Week High | $43.99 | $176.38 |
| Indicator | GLBE | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 41.67 |
| Support Level | $37.28 | $132.80 |
| Resistance Level | $41.77 | $167.79 |
| Average True Range (ATR) | 1.48 | 7.33 |
| MACD | -0.24 | -1.75 |
| Stochastic Oscillator | 26.04 | 8.32 |
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.